EFTUD2 and Miyoshi myopathy: We found that downmodulation of EFTUD2 levels actually correlated with reduced proliferation (Fig. 6B), and that the extent of such reductions correlated with the reduction of EFTUD2 levels (Fig. 6A), confirming the putative oncogenic role of EFTUD2 in MM.